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AbstrAct
Introduction Indigenous women have the highest 
smoking prevalence during pregnancy (47%) in Australia. 
Health professionals report lack of knowledge, skills 
and confidence to effectively manage smoking among 
pregnant women in general. We developed a behaviour 
change intervention aimed to improve health professionals’ 
management of smoking in Indigenous pregnant 
women—the Indigenous Counselling And Nicotine (ICAN) 
QUIT in Pregnancy. This intervention includes webinar 
training for health professionals, an educational resources 
package for health professionals and pregnant women, 
free oral nicotine replacement therapy (NRT) for pregnant 
women, and audit and feedback on health professionals' 
performance. The aim of this study is to test the 
feasibility and acceptability of the ICAN QUIT in Pregnancy 
intervention to improve health professionals' provision of 
evidence-based culturally responsive smoking cessation 
care to Australian Indigenous pregnant smokers.
Methods and analysis This protocol describes the 
design of a step-wedge cluster randomised pilot study. Six 
Aboriginal Medical Services (AMSs) are randomised into 
three clusters. Clusters receive the intervention staggered 
by 1 month. Health professionals report on their knowledge 
and skills pretraining and post-training and at the end of 
the study. Pregnant women are recruited and followed 
up for 3 months. The primary outcome is the recruitment 
rate of pregnant women. Secondary outcomes include 
feasibility of recruitment and follow-up of participating 
women, and webinar training of health professionals, 
measured using a designated log; and measures of 
effectiveness outcomes, including quit rates and NRT 
prescription rates.
Ethics and dissemination In accordance with the 
Aboriginal Health and Medical Research Council 
guidelines, this study has been developed in collaboration 
with a Stakeholder and Consumer Aboriginal Advisory 
Panel (SCAAP). The SCAAP provides cultural consultation, 
advice and direction to ensure that implementation is 
acceptable and respectful to the Aboriginal communities 
involved. Results will be disseminated to AMSs, Aboriginal 
communities and national Aboriginal bodies.
registration details This protocol (version 4, 14 October 
2016) is registered with the Australian and New Zealand 
Clinical Trials Registry (Ref #: ACTRN12616001603404).
IntroductIon
Tobacco smoking in pregnancy is the most 
important preventable risk factor for poor 
maternal and infant health outcomes.
In 2013, 12% of women who gave birth in 
Australia smoked during pregnancy.1 Indig-
enous Australian women have the highest 
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Protocol
strengths and limitations of this study
 ► This is the first study in Australia to target specifically 
Indigenous smoking during pregnancy that covers 
three different states and different settings.
 ► This study is designed to overcome specific 
implementation issues identified in previous 
research, including ensuring community 
representation in governance of the research; 
participant recruitment by known health staff from 
the service; and adequate reimbursement for time 
and effort of services and women.
 ► The intervention tested in this study was informed by 
theory and based on extensive formative research 
beforehand.
 ► This study is a pilot study aimed to assess feasibility 
and acceptability, and is not powered to assess the 
effectiveness of the intervention.
 ► This study covers health professionals treating 
Indigenous pregnant women who work at Aboriginal 
Medical Services only, and does not cover other 
general antenatal care settings that Indigenous 
women may attend.
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smoking prevalence during pregnancy (47%).1 Indig-
enous women also quit smoking during pregnancy at a 
lower rate compared with the general population (11% 
compared with 25%).1 Smoking has been identified as an 
important contributor to the health and life expectancy 
gaps between the Indigenous and non-Indigenous people 
in Australia.2
barriers to quitting
Australian Indigenous pregnant women face multiple 
barriers to quitting smoking.3–6 These include social 
norms of smoking in some Indigenous communities, 
multiple life stressors, lack of prioritisation of smoking 
cessation, lack of support for cessation, lack of salience of 
antitobacco messages and inadequate access to targeted 
programmes.4 5 7 Health professionals report they are 
ill-equipped to tackle the complexities of smoking cessa-
tion care for pregnant women, and lack resources and 
optimism.8 9 First-line medications (oral nicotine replace-
ment therapy (NRT)) are currently not subsidised in 
Australia,3 disproportionally impacting lower socioeco-
nomic populations and Indigenous women.10
Evidence for smoking cessation care in pregnancy
The combination of behavioural counselling and phar-
macotherapy has been shown to be the most effective 
treatment for smokers generally.11 Studies specific to 
pregnant women have also shown that psychosocial inter-
ventions such as counselling are effective.12 Recently 
a taxonomy was developed and validated to detail the 
specific ‘active ingredients’ of behavioural counselling 
termed behaviour change techniques.13–15 These include, 
for example, goal setting and identifying smoking trig-
gers.16
Pharmacotherapy
In a Cochrane review on pharmacotherapy for smoking 
cessation in pregnancy, the use of NRT increased cessa-
tion rates by 40% (RR 1.41, 95% CI 1.03 to 1.93); the 
exclusion of non-placebo controlled trials resulted in a 
lower, non-significant increase in the cessation rate (RR 
1.28, 95% CI 0.99 to 1.66).17 The discrepancy between 
these findings, and the apparent effectiveness of NRT for 
the general population,18 may be explained by the faster 
nicotine metabolism in pregnancy, requiring higher doses 
than those used in the included studies.17 19 20 Importantly, 
the use of NRT was not associated with any significant 
differences in pregnancy or birth outcomes.17 Experts 
agree that NRT is always safer than smoking in pregnancy, 
and guidelines from several countries, including Australia, 
recommend the use of NRT, if a woman has been unsuc-
cessful in quitting.21–24 These guidelines recommend first 
using oral forms of NRT, and if the woman is still unsuc-
cessful quitting smoking, adding an NRT patch. This is 
done to ensure that the lowest effective dose is used.22 25
need for health professionals’ training
Health professionals report that they lack the knowledge, 
skills and confidence to assist pregnant women to quit 
smoking. A recent national Australian cross-sectional 
survey9 found that few general practitioners (GPs) 
and obstetricians routinely perform all of the required 
components of the clinical guidelines.11 26 Furthermore, 
only 11% reported always prescribing NRT, 7% arranging 
follow-up, 22% discussing the psychosocial context of 
smoking and 26% referring to a specialised cessation 
programme (such as the national Quitline). Surveys with 
other antenatal health professionals in Australia (Aborig-
inal health workers, midwives, nurses) report similar 
findings.8
These findings mirror surveys internationally,25 27–39 
portraying an evidence-practice gap in the way health 
professionals currently manage smoking in pregnant 
women.
Addressing this gap is crucial, as it has been shown that 
advice from health professionals increases the chances of 
a quit attempt in the general population (RR 1.66, 95% CI 
1.42 to 1.92),40 and is positively associated with intention 
to quit in Australian Indigenous smokers of reproductive 
age (OR 3.82, 95% CI 1.43 to 10.2).41 Training health 
professionals has been proven to increase rates of smoking 
cessation (OR=1.60, 95% CI 1.26 to 2.03),42 although this 
has not been studied specifically for Indigenous pregnant 
women.
Interventions for pregnant Indigenous smokers
Interventions developed to address smoking in Indige-
nous people have often lacked either rigorous evaluation 
or deep cultural understanding.43 44 Two randomised 
controlled trials (RCTs) among Indigenous pregnant 
smokers have been conducted: one in Indigenous Austra-
lians, and the other in Alaska native women.45 46 Neither 
demonstrated any statistically significant differences 
between intervention and control groups, although the 
underpowered Eades’ study found an assisted quit rate 
of 11% compared with a control rate of 5%.45 46 Several 
implementation factors marred the outcomes of these 
studies, including low enrolment, high attrition and 
possible contamination between study arms.45 46 Patten’s 
study included NRT only through referral to a separate 
programme;46 Eades’ study included an option for NRT 
at the third visit, after 7–10 days of unsuccessful quit 
attempts.45
the Indigenous counselling and nicotine (IcAn) QuIt in 
Pregnancy intervention
In 2015, a pragmatic guide to the management of 
smoking cessation in Indigenous pregnant women was 
published.47 These guidelines are structured on the ABC 
pathway (Ask about tobacco use; Brief advice to quit; 
Cessation support),23 with the addition of a D compo-
nent (Discuss the psychosocial context of smoking)47 the 
ABCD approach. A proactive approach is recom-
mended—offering assistance to all pregnant smokers 
(regardless of readiness to quit and smoking level) and 
an expedited offer of NRT after 1–2 days of an unsuc-
cessful quit attempt.47 These guidelines follow other 
Australian clinical guidelines, recommending the use of 
oral NRT as first line, higher doses of NRT due to the 
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Figure 1 Schematic illustration of the step-wedge cluster study for the Indigenous Counselling And Nicotine (ICAN) QUIT in 
Pregnancy Pilot Study.
higher metabolism in pregnancy and combination NRT 
if needed.21,48,49
On the basis of these ABCD guidelines,47 we used 
the Theoretical Domains Framework,49 the Behaviour 
Change Wheel50 and Behaviour Change Techniques 
recommended in pregnancy,16 to develop a theory-based 
behaviour change intervention aimed to improve health 
professionals management of smoking in Indigenous 
pregnant women—ICAN QUIT in Pregnancy. The Theo-
retical Domains Framework and Behaviour Change Wheel 
are used to identify barriers and facilitators to achieving 
evidence-based care to inform intervention design.50
The intervention was developed in collaboration and 
negotiation with two Aboriginal Medical Services (AMSs) 
in New South Wales (NSW). The chief executive offi-
cers of those AMSs are associate investigators on the 
study and partnered with the research team to establish 
a Stakeholder and Consumer Aboriginal Advisory Panel 
(SCAAP), to advise on the design of the study. They also 
contributed to a working party including AMSs staff 
and community members that developed educational 
resources for the intervention. This collaborative process 
of intervention development has been described else-
where.51
The aim of this study is to test the feasibility and accept-
ability of the ICAN QUIT in Pregnancy intervention to 
increase health professionals' provision of evidence-
based, culturally responsive smoking cessation care to 
Australian Indigenous pregnant smokers, positioning 
Aboriginal women and communities at the centre of 
the research with engagement and ownership upheld 
through the study.51 This study will inform the final 
design and implementation of a clustered RCT (cRCT) 
aimed to study the effectiveness of health professionals' 
training on smoking cessation rates in pregnant Austra-
lian Indigenous smokers.
MEthods And AnAlysIs
Study overview
The overall objective is to reduce smoking in Aboriginal 
and/or Torres Strait Islander pregnant women.
Specific aims of this pilot are:
Primary aims
Assess feasibility and acceptability of a multicomponent 
targeted intervention to train health professionals at AMSs 
in the culturally responsive management of smoking in 
Australian Indigenous pregnant women.
secondary aims
1. Assess the effectiveness on NRT prescribing practices.
2. Evaluate the effectiveness on health professionals' 
knowledge, attitudes and practices in managing 
smoking in pregnant Indigenous women.
3. Estimate the trends for quit attempts and biochemically 
verified smoking cessation rates in pregnant patients 
managed by trained health professionals.
4. Assess patients' perceived receipt and quality 
of smoking cessation care by the trained health 
professionals.
5. Evaluate changes in the perceived well-being of 
pregnant patients.
6. Evaluate behaviour change techniques use by the 
trained health professionals.
Study design
This is a step-wedge cluster randomised pilot study with 
six participating sites randomised to three clusters (each 
of two AMSs). Allocation of the sites to the clusters is 
based on geographical convenience. For each cluster, 
the period of treatment crossover was randomised using 
simple randomisation. Allocation concealment was not 
possible. All of the sites will receive the same intervention 
which will be sequentially delivered 2 months following 
commencement of the study, staggered by 1 month 
between clusters (the intervention is described below). 
Two cohorts, one of health professionals and one of preg-
nant women, will provide data with repeated measures: 
from 2 months prior to receiving the intervention until 
6 months following the intervention. See figure 1 for a 
schematic illustration.
A step-wedge design was chosen since it allows the 
intervention to be delivered sequentially and therefore 
reduces the cost and burden of simultaneous implemen-
tation, while also providing some control of confounding 
factors through randomisation.52 Furthermore, this 
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design will ensure all sites receive the intervention which 
is important from an ethical viewpoint. The cluster design 
was chosen to prevent contamination, a problem identi-
fied in the Eades’ study.45
timeline of the study
November 2016 to September 2017.
setting
Urban and regional AMSs in NSW, Queensland and South 
Australia. The AMSs include Aboriginal Community 
Controlled Health Services which are non-government 
organisations operated by local Aboriginal and Torres 
Strait Islander communities, to deliver holistic, compre-
hensive and culturally appropriate healthcare to the 
communities that control them through an elected board 
of management.53
Inclusion criteria
For participating services AMSs are included if they fulfil 
all of the following criteria:
1. Diagnose pregnancy or provide antenatal or routine 
care for pregnant Aboriginal or Torres Strait Islander 
women.
2. Employ at least one General Practitioner (GP).
3. Have contact with at least 20 pregnant women who 
smoke per year.
4. Are able to recruit and follow patients as required.
Participating health professionals are those who: consult 
with pregnant women either for confirmation of preg-
nancy, antenatal care and/or routine care.
Participating women will include those who fulfil all of 
the following criteria:
1. Pregnant, ≤28 weeks gestation.
2. Aboriginal and/or Torres Strait Islander or expectant 
mothers of Aboriginal and/or Torres Strait Islander 
babies.
3. Aged ≥16 years old.
4. Smoke tobacco at any level of consumption, including 
those that only smoke occasionally.
Intervention components
The ICAN QUIT in Pregnancy intervention includes:
 ► Training of health professionals in participating sites 
through webinar in three 60-min weekly sessions. The 
training will be delivered by two experienced tobac-
co treatment specialists. Content will include back-
ground on smoking in pregnancy including the In-
digenous context; the ABCD approach, and the use 
of NRT in pregnancy (see  online supplementary file 
for full description of webinar content). As an incen-
tive to complete the training, all health professionals 
will be offered continuing professional development 
points (required as part of registration with the Aus-
tralian Health Practitioner Regulation Agency).
 ► An educational resources package, to be used by 
both health professionals and pregnant women, has 
been developed collaboratively and includes a train-
ing manual for health professionals, and flip chart, 
patient booklet and educational posters for engaging 
with the pregnant women. Resources were developed 
by a medical doctor and tobacco treatment specialist 
(YBZ) and Aboriginal researcher (MB) in consulta-
tion with AMSs. These have been rigorously pretested 
using a four-step process, including review by an ex-
pert panel, assessment using a suitability of material 
score by two Aboriginal health workers, readability 
scores, and focus groups reviews with both health pro-
fessionals, and female Aboriginal community mem-
bers, in three states.54
 ► Oral forms of NRT for the pregnant women will be 
supplied to the sites free of charge, as these are not 
currently subsidised in Australia. All available forms 
in Australia will be included (gum, lozenge, mini loz-
enge, inhalator and spray). NRT will be dispensed 
through a voucher system. Sample packs will be pro-
vided directly to the sites to introduce patients to the 
selection available. If NRT patches are required, the 
GP at the service will write a government-subsidised 
prescription. NRT will be used according to prod-
uct and Therapeutic Goods Administration instruc-
tions, as well as health professionals' judgement on 
a patient-by-patient basis. No study-specific protocol 
to NRT dispensing will be followed. As nicotine has 
potential effects on the fetus,55 56 a risk-benefit anal-
ysis will be undertaken with each woman when NRT 
is offered, as recommended in clinical guidelines.21 
A participant not using NRT can remain in the study 
with behavioural support only.
 ► Audit and feedback regarding health professionals' 
performance will be via aggregated, deidentified, ser-
vice-specific, monthly data collection, commencing 
in the pretraining phase and continuing through to 
study completion. Each service will receive feedback 
regarding their rate of NRT prescription to pregnant 
women who smoke compared with other study servic-
es.
Study implementation
A staff member will be nominated as a research facili-
tator by each service. The role of the research facilitator 
is to recruit patients, conduct surveys and evaluations, 
and collect feasibility data (table 1). The research 
facilitator will be trained by the research team in a face-
to-face meeting and provided with supporting resources 
(detailed instructions and checklist) to assist them in 
their role. The research team will provide three site visits 
(before commencement, 1 month after commencement 
and end of study) and weekly telephone calls as imple-
mentation support. Additional support will be provided 
as needed by the research facilitator.
recruitment and reimbursement
Services will be recruited through: (1) written invitation 
to all AMSs in NSW asking for expressions of interest, 
and (2) targeted invitations to services that worked previ-
ously with the researchers. The service will be reimbursed 
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Table 1 Feasibility and acceptability outcomes
Hierarchy of 
measurement (service, 
Health Professionals or 
pregnant women) Outcome
Data collection 
method Analysis Time-points
Service Recruitment rate 
(primary outcome)
Research 
facilitator log
Number of women recruited divided by 
number of women approached for each 
site, overall sites and stratified by site
End of study
Service Follow-up rate Participant 
survey
Percentage of women recruited who 
complete all follow-up surveys
4 weeks and 
12 weeks
Service Proportion of 
women’s checklists 
completed
Women’s 
checklist
Number of consultations with a 
completed checklist divided by the total 
number of consultations for each patient 
(designated and non-designated study 
visits)
End of study
Service Provider training rate Research 
facilitator log
Number of providers undergoing 
webinar training divided by the total 
number of providers, overall sites and 
stratified by site
End of training
Service Webinar completion 
rate
Research 
facilitator log
Number of webinar sessions each 
provider attended
End of training
Health professionals and 
pregnant women
Acceptability of 
intervention and 
implementation
Interviews 
with staff and 
patients
Thematic analysis End of study
$6000 in instalments, for the involvement of their nomi-
nated research facilitator.
Service staff will aim to recruit all pregnant smokers 
under their care when they attend for any type of service 
including confirmation of pregnancy, antenatal care or 
routine care. The study will be advertised through posters 
at the service.
The research facilitator will complete a one-page eligi-
bility checklist with women interested in the study, and if 
they are eligible, will gain informed consent. Consenting 
women will be assigned a unique code to link the data 
collected to the same participant. Pregnant women 
recruited to the study will be asked to attend three desig-
nated study visits (baseline at recruitment, 4 weeks and 
12 weeks postrecruitment). At each study visit, the partici-
pating women will be asked to fill out two to three online 
surveys and perform a breath carbon monoxide test. We 
estimate that each study visit will take between 30 min and 
50 min.
Women will receive reimbursement for their time in 
the form of a $A20 shopping voucher for each visit (total 
$A60). Women attending all three study visits will enter 
into a draw for one baby pack (value $A50) per site.
outcomes
Outcomes include feasibility and acceptability measures, 
and measures of effectiveness outcomes (detailed descrip-
tion of all the outcomes are presented in tables 1 and 
2). The primary outcome will be the recruitment rate of 
participating pregnant women defined as the number of 
eligible women who consented to participate in the study.
data collection and instruments
Data will be collected at three levels—(1) service (2) 
health professionals and (3) pregnant women (tables 1 
and 2). Participant timelines are presented in table 3 
(health professionals) and table 4 (pregnant women).
Service level
Research facilitator log
Feasibility data will be collected by the research facil-
itator using a designated log, including recruitment 
rate, follow-up rate, proportion of participant surveys 
completed and health professionals' training rate. Reasons 
for non-participation or withdrawal will not be collected 
routinely as part of the research facilitator designated log, 
but will be discussed with the research facilitator on an 
ongoing basis in the weekly implementation phone calls 
and at the end of the study interview.
Aggregated computerised data
Deidentified aggregated monthly computerised data 
will be collected from study commencement (figure 1), 
including: number of pregnant women attending the 
service; number of those that smoke; number referred to 
the Quitline and number of NRT prescriptions (including 
oral NRT vouchers).
Health professionals level
Health professionals' survey
A 102-item, 15 min, self-administered online survey will 
include questions about health professionals' demo-
graphic characteristics; self-reported knowledge, attitudes 
and provision of smoking cessation care; prescription 
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Table 3 Schedule of assessments for health professionals receiving training for Indigenous Counselling And Nicotine (ICAN) 
QUIT in Pregnancy Pilot Study
Assessment Performed by
Pretraining Post-training End of study
_ _/_ _/_ _ _ _
(dd/mm/yyyy)
_ _/_ _/_ _ _ _
(dd/mm/yyyy)
_ _/_ _/_ _ _ _
(dd/mm/yyyy)
Informed consent Research facilitator X
Pretraining survey Self-administered online X
Audio recording of smoking 
consultations (optional)
Health professional X X
Post-training survey Self-administered online X X
Interview Research team X
Table 4 Schedule of assessments for pregnant women participating in Indigenous Counselling And Nicotine (ICAN) QUIT in 
Pregnancy Pilot Study
Assessment Performed by
Day 0
Any additional 
follow-up*
4 weeks
(+/−3 days)
12 weeks
(+/−7 days) End of study
_ _/_ _/_ _ _ _
(dd/mm/yyyy)
_ _/_ _/_ _ _ _
(dd/mm/yyyy)
_ _/_ _/_ _ _ _
(dd/mm/yyyy)
_ _/_ _/_ _ _ _
(dd/mm/yyyy)
_ _/_ _/_ _ _ _
(dd/mm/yyyy)
Review eligibility for 
study
Health professional 
and/or research 
facilitator
X
Informed consent Research facilitator X
Smoking 
characteristics 
survey
Research facilitator X X X
Growth and 
Empowerment 
survey
Research facilitator X X X
Critical Success 
Measures survey
Research facilitator X
Breath carbon 
monoxide test
Research facilitator X X X
Patient checklist Research facilitator X X X X
Audio recording 
of smoking 
consultation 
(optional)
Health professional X X X
Interview Research team X
*Any additional follow-up (not part of designated study visits) including all of her visits to the service for usual care.
of NRT; self-assessment of the barriers and enablers to 
providing smoking cessation care; and perceived useful-
ness of educational resources. This survey is based on 
a previous survey from a national study of 378 GPs and 
obstetricians.9 The survey will be sent pretraining and 
post-training, and at the end of the study (table 3).
Health professionals' demographic characteristics 
include: gender, age, years working as a health profes-
sional (less than 10 years; 10–19 years; 20 or more years), 
specialty (GP; midwife; nurse; Aboriginal health worker; 
other), smoking status (daily; occasionally, ex-smoker, 
never smoked) and average number of pregnant women 
who smoke seen per month (<5, 5–10,>10).
Self-reported provision of smoking cessation care: will 
be measured using 5-point Likert Scales (never (0%); 
occasional (1%–25%); sometimes (26%–50%); often 
(51%–75%); always (76%–100%)) on the various compo-
nents of smoking cessation care (‘How often do you 
provide the following types of cessation care with preg-
nant women?’ ask; record smoking status; brief advice; 
assess nicotine dependence; measure carbon monoxide; 
cessation support; discuss psychosocial context; follow-up; 
referral to Quitline; referral to other specialist cessation 
support; involve family members).
Prescription of NRT and attitudes towards prescribing 
NRT during pregnancy: NRT prescription will be 
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measured with the 5-point Likert Scale as for the other 
smoking cessation care components. Self-reported 
perceptions on NRT in pregnancy will include rating 
the safety for the fetus, effectiveness in aiding pregnant 
smokers to quit and perceived adherence.
Barriers and enablers to smoking cessation care: 
(5-point Likert Scales—strongly disagree, to strongly 
agree). This will be measured using 22 statements covering 
13 domains from the Theoretical Domains Framework,50 
including: knowledge, reinforcement, role/identity, 
beliefs about capabilities, optimism, beliefs about conse-
quences, social influence/subjective norm, goals/
priority, memory/attention, environmental context and 
resources, emotions/stress, intentions, behavioural regu-
lation. Most domains include one question regarding 
smoking cessation care during pregnancy in general, and 
one question specifically regarding the prescription or 
recommendation of NRT.
The ‘Knowledge’ domain will also be measured with 
one question about guidelines ('Have you read any of 
the following smoking cessation guidelines?' With a 
list of 3 different national guidelines, yes/no); and 24 
true/false statements that will be computed to form a 
composite score. The ‘Skills’ domain will be measured 
with one question ('Have you received any training in 
tobacco management related to pregnancy? with a list of 
4 training types' yes/no).
Usefulness of educational resources will be measured 
using 5-point Likert Scales (not useful at all to very useful) 
for each webinar session and each educational resource.
Interviews
At the conclusion of the study, one of each type of health 
professionals from each service (ie, a midwife, a GP and 
an Aboriginal health worker), including also the manager 
and research facilitator, will be interviewed. Recruitment 
will continue until saturation of themes. Estimated sample 
n=40. The objective of the interviews is to assess the feasi-
bility of the intervention and the study, and gain valuable 
insights before commencing the cRCT. The semistruc-
tured interview guide will include questions based on the 
Theoretical Domains Framework and Behaviour Change 
Wheel,49 50 and include topics such as the challenges to 
implementing the study, and what could have been done 
to improve the study.
Pregnant women level
Smoking characteristics survey
This 56-item, 15 min, survey will incorporate questions 
from a previously tested survey in Aboriginal pregnant 
smokers.57 Demographic and smoking characteristics 
will include: age, Aboriginal and Torres Strait Islander 
status, partner status, parity, number of children, any 
child living at home, smoking status, measures of 
nicotine dependence (Fagerstrom Test of Nicotine 
Dependence,58 Heaviness of Smoking Index,59 strength 
and frequency of urges to smoke60 61), home smoking 
rules, intentions to quit smoking, number of previous 
quit attempts ≥24 hours, use of other smoking cessation 
resources (such as the Quitline), symptoms of nausea 
in pregnancy (morning sickness is a predictor of spon-
taneous quitting62), the Risk Behaviour Diagnosis Scale 
(previously validated in Aboriginal smokers, adapted 
here for pregnant smokers63), and attitudes to smoking 
and quitting. Adherence to NRT will be measured using 
a 5-item multichoice question (did not take it all; used 
occasionally 1–2 times a week; used 3–4 times but not all 
doses; occasionally missed a dose; used most doses, every 
day).
At the 4-week and 12-week follow-ups, the survey 
includes additional questions to determine 7-day point 
prevalence smoking abstinence and continuous absti-
nence rates.64
Growth and empowerment measure (GEM)
This survey has been previously validated with 184 Indig-
enous Australians, but has not been used specifically with 
Indigenous pregnant women65 and includes two compo-
nents:
1. 14-item Emotional Empowerment Scale which 
comprises two domains: inner peace and self-capacity.
2. 12 Scenarios with two domains: healing and enabling 
growth and connection and purpose.
These are accompanied by the 6-item Kessler Psycho-
logical Distress Scale supplemented by two questions 
assessing frequency of happy and angry feelings. Esti-
mated completion time is 15 min.
Critical success measure
This measure was developed through analysis of six 
Indigenous youth social and emotional well-being 
programmes66 and was previously used in the evaluation 
of an urban art-based community health programme with 
young Aboriginal and Torres Strait Islander parents.67 
This survey will be completed only once at the 12-week 
visit. This survey will measure nine factors relevant to an 
empowerment-based programme, including adopting 
full commitment to working from strengths; being 
patient to develop the relationship bond first; modelling 
reliability and being consistent; facilitating connection to 
culture; adopting a non-judgemental approach; setting 
rules and boundaries; modelling openness, honesty, hope 
and trust; maximising opportunity for choice making, 
self-motivation, feeling safe to try new things; celebrating 
small achievements and positive changes. For each factor, 
we will use 5-point Likert Scales to measure women’s 
perception of the importance of the factor (from not at 
all to absolutely essential) and how well the intervention 
achieves this (from poorly to extremely well). Estimated 
completion time is 15 min.
Breath carbon monoxide
At the three study visits, a breath carbon monoxide test 
will be performed to validate smoking status, and estimate 
fetal carboxyhaemoglobin. Carbon monoxide level ≥5 
ppm=96% sensitivity and 99.6% specificity for agreement 
of carbon monoxide readings and self-report of smoking 
in Aboriginal communities.68
group.bmj.com on August 14, 2017 - Published by http://bmjopen.bmj.com/Downloaded from 
 9Bar-Zeev Y, et al. BMJ Open 2017;7:e016095. doi:10.1136/bmjopen-2017-016095
Open Access
Women’s checklist
At the end of any visit to the service, from recruitment 
to the end of follow-up, including the designated study 
visits at 4 weeks and 12 weeks, the patient will be asked to 
complete a 1 min online checklist on a computer tablet. 
The survey will commence with a question regarding 
which health professional she saw on that occasion (GP/
midwife/nurse/Aboriginal health worker/other). Eleven 
dichotomous questions (yes/no) will be used to form a 
composite score representing quality of smoking cessa-
tion care. For example: Did any of the health professionals you 
saw today give you the following care: Asked you about smoking? 
Gave you advice to quit…? Assisted you with making a quit 
plan? Explained how smoking affects…? Offered you NRT…? 
Measured your breath…? /Discussed with you…? Gave you 
support…? Made arrangements for follow-up appointments 
or referral? Gave you resources…? Two Likert Scales will be 
used to rate (1) her perceived involvement in making a 
decision about quitting (no involvement to very much 
involved) and (2) her overall satisfaction with the help 
she received (not satisfied at all to very satisfied).
Recording of consultations for behaviour change techniques 
analysis
A digital audio recording of provider-patient sessions 
relating to smoking cessation will be undertaken, 
including a mix of initial and follow-up consultations 
(ie, prequit attempt, and during or postquit attempt up 
to the 4-week follow-up point). A total estimate of 54 
consultations will be recorded (nine consultations per 
service—three pregnant smokers from each service, for 
each woman, three consultations as outlined above).
Interviews
At the conclusion of the study, approximately three 
to four women from each service, will be interviewed 
to assess the feasibility of the intervention and related 
research in order to gain insights before the cRCT. Key 
topics to be discussed include their perceptions of the 
usefulness, acceptability and potential effectiveness of 
the support they received as part of the study, and what 
could have been done to improve this. Recruitment will 
continue until saturation of themes.
sample size calculation
Health professionals' sample: expected sample size will be 
six services, training 5–10 per service, with total sample 
size of n=30–60 recruited health professionals. Expected 
completion of training is 80%.
Pregnant women’s sample: expected recruitment is 
10 eligible consenting women per service n=60 (range 
50–80). Assuming a true recruitment rate of 50%, a 
sample of 200 eligible women will allow estimates of the 
true recruitment rate within a 7% margin of error.
data analysis plan
Recruitment rates (and other feasibility outcomes spec-
ified in table 1) will be estimated as proportions (or 
percentages) with 95% CIs, SEs will be adjusted for the 
clustered design using the clustered jackknife.69 All 
primary analysis will be according to the intention-to-treat 
principle, such that each site (and participants within) 
will be analysed according to the time at which the site 
crossed over to the intervention period.
Analysis of effectiveness outcome measures
1. Changes in the proportion of eligible women that 
were prescribed NRT from pretraining to post-
training will be assessed using a logistic mixed effects 
regression model. The model will include a categorical 
effect of time, an indicator of period (pretraining vs 
postintervention) and a random intercept for each 
site.
2. Changes in provider knowledge/attitudes relating to 
smoking cessation in pregnant mothers measured by 
self-administered survey: pretraining to post-training 
and end of study will be investigated using generalised 
linear mixed effects models, with random effects for 
the site and the health professionals, and fixed effects 
for time. If the fraction of missing data is less than 
5% the primary method will be based of those with 
completed surveys from both time points. Otherwise 
we will use multiple imputation under the missing at 
random assumption, with a sensitivity analysis using 
pattern mixture models to explore the potential that 
data is missing not at random.
3. Trends in smoking characteristics and growth and 
empowerment, and factors associated with smoking 
characteristics and growth and empowerment, will be 
assessed using generalised linear mixed models.
4. Two certified behaviour change techniques coders will 
independently code the transcribed audio recordings. 
Discrepancies will be resolved through discussion 
with a third coder. Coding will be based on the 
taxonomy of 44 smoking cessation behaviour change 
techniques.15 16 Additionally, the two coders will 
independently code the training resources. Inter-
rater agreement levels will be calculated. We will 
assess changes between behaviour change techniques 
present pretraining and post-training; and the fidelity 
between the behaviour change techniques present in 
the training resources and those present in the post-
training recordings.
5. Interviews at the end of the study will be audio recorded, 
transcribed and analysed (using NVivo software) 
with a framework analysis70 based on the Theoretical 
Domains Framework and Behaviour Change 
Wheel.49 50 Two researchers will independently open 
code and index a 20% proportion of the transcripts 
line by line, using a predetermined coding matrix. 
After coming to consensus, one researcher will then 
complete the coding and indexing. If appropriate, 
inductive themes will be included after discussion 
between the two researchers.
Ethics and dissemination
We will follow Australian National Health and Medical 
Research Council ethical guidelines for research, 
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including Aboriginal and Torres Strait Islander research, 
consistent with the Declaration of Helsinki.71
The Stakeholder and Consumer Aboriginal Advisory 
Panel (SCAAP) invites at least one member from each 
of the pilot study AMSs and will convene bimonthly. The 
role of the SCAAP will be to provide cultural consultation, 
advice and direction to ensure that the implementation of 
the ICAN QUIT in Pregnancy project pilot is acceptable 
and respectful to the Aboriginal communities involved. 
The SCAAP is instrumental in ensuring research prac-
tice, data collection and dissemination of findings is 
appropriate to each community. Members of SCAAP will 
be included in the writing and publication of research 
results.
Furthermore, an Aboriginal cultural liaison position is 
maintained throughout the study to ensure appropriate 
level of cultural safety, Aboriginal community ownership 
and engagement is upheld. The research team includes 
three Aboriginal chief investigators and four Aboriginal 
associate investigators who are involved in various aspects 
of the project, including the design, implementation, 
data analysis and interpretation.
Pregnant smokers who are mature minors (aged over 
16 years but under 18 years) will be included if judged 
by the research facilitator able to give informed consent. 
Consent to the audio recording is an additional option 
for both health professionals and participating pregnant 
women, which they can agree to or decline.
All of the data collected, at all levels, are deidentified. 
Pregnant women participating in the study are given a 
unique code by the research facilitator. Any data collected 
are only identified with this code. Health professionals' 
surveys are linked using the date of birth and the last 
three digits of their surname.
All serious adverse events, and study related adverse 
events considered severe in nature that do not otherwise 
fulfil the definition of a serious adverse event, will be 
reported immediately by sites during follow-up. For the 
purposes of this study those events that will be considered 
severe study related adverse events include, but are not 
limited to, severe allergic reaction to NRT and clinical 
depression. A data monitoring committee will not be 
convened for this study and was not deemed necessary 
by the human research ethics committee, as NRT will be 
used according to current clinical guidelines.
Study outcomes will be discussed with participating 
services. Sites will receive a lay summary of the study 
outcomes, to be distributed to their community and 
participants of the study as they see fit. A policy brief 
will be distributed to Aboriginal and Government peak 
bodies.
significance of the study
The ICAN QUIT in Pregnancy intervention trial was 
designed to overcome implementation problems identi-
fied in previous research.45 46 72 73 74 This includes ensuring 
community representation in governance of the research; 
participant recruitment by known health staff from the 
service; adequate reimbursement for time and effort of 
the services and women participants. This pilot phase will 
enable us to test the feasibility and acceptability of the 
intervention, and make further adjustments as necessary, 
prior to the expense of a large cRCT. The ICAN QUIT 
in Pregnancy pilot trial will provide valuable information 
to advance the much needed reduction in smoking rates 
among pregnant Indigenous women.
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